The combined oral contraceptive pill has been used by an estimated 300 million women worldwide since it was first developed. In recent years it has been linked with both an increased risk of some forms of cancer and a protective effect against other cancers – leading to considerable confusion for women. In order to provide much-needed clarity, Dr Richard Russell and Mr Charles Kingsland provide an overview of the risks and benefits of the combined oral contraceptive pill.